{"disease":{"id":"eczema-infantile","name":"eczema infantile"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03742414","title":"Seal, Stopping Eczema and Allergy Study","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":398,"lead_sponsor_name":"Kari Nadeau, MD, PhD","has_results":false},{"nct_id":"NCT03871998","title":"Short-term Topical Application to Prevent Atopic Dermatitis","phase":"NA","overall_status":"COMPLETED","enrollment_count":321,"lead_sponsor_name":"University College Cork","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}